To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"Our next step is to find out if this [a functional 'cure'] is a highly unusual response to very early antiretroviral therapy or something we can actually replicate in other high-risk newborns." ?Dr. Deborah Persaud

A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.

A report on the case was presented at a press conference on Sunday, March 3, at the 20th Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta. Johns Hopkins Children's Center virologist Deborah Persaud, M.D., lead author on the report, and University of Massachusetts Medical School immunologist and professor Katherine Luzuriaga, M.D., headed a team of laboratory investigators. Pediatric HIV specialist Hannah Gay, M.D., associate professor of pediatrics at the University of Mississippi Medical Center provided treatment to the baby. (Photo: Dr. Katherine Luzuriaga)

The infant described in the report underwent remission of HIV infection after receiving antiretroviral therapy (ART) within 30 hours of birth. The investigators say the prompt administration of antiviral treatment likely led to this infant's cure by halting the formation of hard-to-treat viral reservoirs?dormant cells responsible for reigniting the infection in most HIV patients within weeks of stopping therapy.

"Prompt antiviral therapy in newborns that begins within days of exposure may help infants clear the virus and achieve long-term remission without lifelong treatment by preventing such viral hideouts from forming in the first place," Persaud says.

The researchers say they believe this is precisely what happened in the child described in the report. That infant is now deemed "functionally cured," a condition that occurs when a patient achieves and maintains long-term viral remission without lifelong treatment and standard clinical tests fail to detect HIV replication in the blood.

In contrast to a sterilizing cure?a complete eradication of all viral traces from the body?a functional cure occurs when viral presence is so minimal, it remains undetectable by standard clinical tests, yet discernible by ultrasensitive methods.

The child described in the current report was born to an HIV-infected mother and received combination antiretroviral treatment beginning 30 hours after birth. A series of tests showed progressively diminishing viral presence in the infant's blood, until it reached undetectable levels 29 days after birth. The infant remained on antivirals until 18 months of age, at which point the child was lost to follow-up for a while and, the researchers say, stopped treatment. Ten months after discontinuation of treatment, the child underwent repeated standard blood tests, none of which detected HIV presence in the blood. Test for HIV-specific antibodies?the standard clinical indicator of HIV infection?also remained negative throughout. (Photo: ITV News)

Currently, high-risk newborns?those born to mothers with poorly controlled infections or whose mothers' HIV status is discovered around the time of delivery?receive a combination of antivirals at prophylactic doses to prevent infection for six weeks and start therapeutic doses if and once infection is diagnosed. But this particular case, the investigators say, may change the current practice because it highlights the curative potential of very early ART.

Specialists say natural viral suppression without treatment is an exceedingly rare phenomenon observed in less than half a percent of HIV-infected adults, known as "elite controllers," whose immune systems are able to rein in viral replication and keep the virus at clinically undetectable levels. HIV experts have long sought a way to help all HIV patients achieve elite-controller status. The new case, the researchers say, may be that long-sought game-changer because it suggests prompt ART in newborns can do just that.

Read more at the link provided.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Long Beach, California Cancels Their Popular July 4th Fireworks Show, Even for America's 250th Birthday, Citing Pollution as the Reason

Digital Nightmare? Anthropic Withholds AI Model Too Dangerous for Humanity

'A Victory for All Pro-Life Oregonians': Federal Judge Rules State Can't Force Oregon Right to Life to Pay for Abortions

10 Republicans Side With Dems to Provide Amnesty to Haitian Illegals

Virginia Dems Pass National Popular Vote Law that Experts Warn Is Unconstitutional

Israel-Lebanon Ceasefire Begins; Trump Says Iran's Regime Agrees to Give Up Having Nuclear Weapons

President Trump: Strait of Hormuz 'Fully Open', Oil Prices Drop

Clarence Thomas Destroys 'Progressivism' in Ruthless Speech

Trump Reveals He Has Multi-Pick SCOTUS Plan Ready as Justice Retirement Speculation Heats Up

Trump Admin Pushes Global Plan to Protect Kids Online

Youth Mental Health Deteriorates after Gender Reassignment Services, Extensive, Long-Term Study Finds

Trump Administration Pulls $11 Million in Funding for Catholic Charities that Sheltered Illegal Alien Minors

Prayer Alert: Former Democrat Lt. Gov. and Wife Found Dead in Apparent Murder-Suicide; Kids Were Home at the Time

Israeli Forces Discover Huge Hezbollah Weapons Cache Inside School; Destroy 70 Hezbollah Terror Sites in Lebanon

US War on Iran's Regime Could Be Ending Soon; Ceasefire between Israel and Lebanon Announced

Melania Trump Joins Lawmakers for Roundtable Discussion on Empowering Foster Care Children

Heroic Oklahoma High School Principal Shot in the Leg as He Tackles Would-Be Shooter Before Gunman Opens Fire on Students (VIDEO)

Teachers' Union Webinar Sparks Indoctrination Fears

'Deadnaming' Is Now Classified as 'Gender-Based Violence' in Liberal Canada

The War on Biology Is Far from Over

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor